Centre for Anaesthesia, University College London Hospitals NHS Trust, London, UK Baroreflex impairment is independently associated with excess post operation morbidity and prolonged hospitalisation. 1 This suggests a mechanistic role for autonomic dysfunction in determining perioperative outcome. However, the time course over which cardiac autonomic function changes perioperatively remains unclear. Elective surgical patients at higher risk of myocardial injury according to VISION criteria 2 (n¼119 patients) were recruited in a prospective single-centre observational study (REC16/LO/ 0635). Serial electrocardiographic (ECG) holter monitoring (Spacelabs Lifecard CF monitor, Spacelabs Healthcare) was undertaken preoperatively, 24 h and 48 h after surgery. We recorded ECG, non-invasive blood pressure and respiratory rate for 10 minutes in the lying position before repositioning the patients at 45 degrees and repeating the tests in order to assess postural autonomic changes. Cardiac autonomic function was assessed using time and frequency domain heart rate variability analyses (Pathfinder Software, Spacelabs Healthcare; Nevrokard aHRV Software). High frequency (HF) domain was used as a marker of cardiac parasympathetic activity and low frequency (LF) domain was used as an indicator of baroreflex activity. 3 For each patient, we assessed changes in autonomic function perioperatively over time and in relation to position (repeated measures ANOVA with post hoc TukeyKramer tests). Figure 4 shows the serial perioperative changes for heart rate, HF and LF (mean and 95% confidence interval). There was a significant increase in heart rate at 48h compared to the preoperative and 24h heart rate in both the lying and 45 degree position. Low frequency and high frequency both significantly decreased after surgery, but only after 24h. Our study shows that a reduction in cardiac vagal modulation develops by 48h after surgery, consistent with our previous data. 4 Loss of LF suggests the development of baroreflex dysfunction. These data suggest that autonomic impairment is acquired in the recovery period after surgery, and therefore potentially modifiable (e.g. with targeted mobilization 5 and/or other therapeutic interventions. Penicillin allergy is the most commonly reported drug allergy, with up to 20% of patients carrying this label. When tested, fewer than 10% of such patients were found to be allergic 1 . Incorrect penicillin allergy labels are potentially harmful, with the label increasing the risk of MRSA and C. difficile, longer hospital stays, and mortality 1 . Testing for penicillin allergy involves skin testing (± serum testing), followed by an oral challenge test when these are negative 2 . However, increasing evidence suggests that patients with a 'low risk' history can safely have a direct oral challenge 2 . If this is tolerated without incident, they are 'de-labelled' and advised that they can receive penicillin in the future. We sought to establish the feasibility of offering this abbreviated testing pathway to 'low risk' elective surgical patients who require penicillin for their surgery.
Patients who self-reported a penicillin allergy during routine pre-assessment were screened for eligibility using a questionnaire. Patients with a 'low risk' and meeting the inclusion criteria were offered to attend on a separate day for delabelling with a graded oral amoxicillin challenge (or the index penicillin to which they were allergic). If there were no signs of allergy within the two hours of completing the challenge, patients went home with a 3-day course of amoxicillin, after which they were contacted to rule out any delayed reactions before being formally de-labelled. The patient, surgeon and GP were informed of the results, and the hospital electronic records updated. The notes of patients were reviewed after surgery to assess which antibiotic had been administered intra-operatively.
Penicillin allergy was self-reported in 80 patients, with fifteen eligible for inclusion. To date, 10 of the eligible group have received the graded oral challenge and none has had any immediate or delayed reactions to the amoxicillin. Six of these patients proceeded to have uneventful surgery with penicillin prophylaxis, with four still waiting. Of the 65 ineligible patients, reasons for ineligibility included: high risk symptoms (36/65), did not require penicillin for surgery (20/65), allergic reaction within fifteen years (16/65), declined testing (15/65), insufficient time for testing prior to surgery (7/65), and medical condition preventing inclusion (3/65).
Our preliminary data demonstrates that patients allergic to penicillin can be identified, risk-stratified then de-labelled using an abbreviated testing pathway prior to their planned surgery. These patients then go on to receive penicillin for their surgery, rather than broad spectrum alternatives. This abbreviated pathway has the potential to enable large-scale 'de-labelling' to benefit individuals, and improve the wider antimicrobial stewardship.
